Investors, vendors, and enterprise buyers should be skeptical. This page answers why Ayra exists when teams already have logs, AI tools, engineers, compliance staff, and internal dashboards.
Show
Why clearinghouses are not enough.
Clearinghouses check syntax. Ayra checks evidence. A clearinghouse can see whether a field is present. Ayra checks whether the proof behind the field is valid, such as time versus CPT code, authorization versus diagnosis, and documentation completeness before the claim leaves your system.
Because payers also use AI. Their systems reject claims faster, often before a human review ever happens. Ayra attaches the evidence bundle upstream so the claim enters the payer path with proof already connected.
Appeals are expensive, slow, and often abandoned when the rework destroys the margin. Ayra is designed to stop preventable denials before transmission, instead of asking teams to recover revenue after the damage is done.
No. Ayra is deterministic, not predictive. Authorization, documentation, and duplicate checks use hard rules. If a clinical judgment is required, Ayra holds and routes the claim to a human reviewer instead of hallucinating an answer.
Why record sending is not enough.
Sending the record is easy. Proving it was legal is hard. Telehealth made clinicians multi-state operators, but state laws still apply. Ayra checks consent scope, license jurisdiction, role, and route safety before the handoff moves, then emits a receipt-backed packet for review.
Safety always wins. Ayra supports a defined Break-Glass path. If an authorized clinician asserts Emergency Status, the handoff can move immediately. The receipt is flagged as a forced override, and compliance teams receive the exception trail for review after the rescue.
Static credentialing can show that a profile or credential was attested at some point. Multi-Hop checks the action itself: who is sending, who is receiving, where the patient is, what consent and source evidence are attached, and whether an attorney-reviewed authority rule pack allows the route at that moment. If the authority proof is missing, the handoff holds and the hold is receipted.
Your AI optimizes for availability. Ayra enforces liability boundaries. If an agent treats state as a preference instead of a legal constraint, Ayra becomes the hard wall that forces the system to choose the best legal route, not just the fastest open slot.
Why not just build this internally?
You can build pieces. The hard part is making proof trusted outside your company: receipts, verifiers, privacy boundaries, rule versions, audit evidence, and maintenance. Ayra keeps that from becoming your side business.
AI lowers cost by moving faster. That also means faster mistakes, denials, and audit exposure. Ayra protects the margin by proving automated actions passed the right checks before they moved.
Agentic AI increases the volume and speed of regulated actions. It can draft, route, and generate, but it still works probabilistically. Ayra adds deterministic checks and receipt evidence before the agent moves the workflow.
No. Ayra sits behind the workflow your product already owns. It is an infrastructure layer for proof, gating, receipts, and verifier-ready evidence. Your product remains the system of record and the user-facing workflow.
What Ayra does and does not claim.
No. Ayra can enforce configured rules and route risky actions, but legal policy, payer policy, and clinical judgment remain with the customer and qualified professionals. When judgment is required, Ayra routes to a human instead of pretending the answer is deterministic.
No. Healthcare AI requires binding controls, documented review, and human accountability where judgment is involved. Ayra does not replace regulatory programs or legal review. It gives teams a structural proof layer so AI agents, claims, and handoffs can be gated, held, routed, and receipted before they create risk.
No. The public proof path is designed around references, hashes, receipts, and approved evidence bundles. Raw patient data can stay inside the customer's controlled systems while outside reviewers recompute whether the proof path still matches.
Ayra Health
Hard questions,
answered plainly.
Investors, vendors, and enterprise buyers should be skeptical. This page answers why Ayra exists when teams already have logs, compliance staff, and internal dashboards.
All
Payer Proof
Multi-Hop
Build vs Buy
Risk
Why clearinghouses are not enough.
Clearinghouses already scrub claims. Why?
If AI reducing denials why rates still rising?
Why not let RCM team handle appeals?
Does Ayra use AI to guess medical necessity?
Why record sending is not enough.
Why is Multi-Hop necessary?
If patient in crisis will Ayra block transfer?
How is Multi-Hop different from CAQH?
Our AI scheduling agent filters for state, why a gate?
